Last updated on November 2019

Lynparza Breast Cancer Clinical Experience Investigation


Brief description of study

To characterise the development of ADRs of bone marrow depression in patients under actual post-marketing use.

Detailed Study Description

To characterise the development of adverse drug reactions (ADRs) of bone marrow depression in patients with unresectable or recurrent BRCA mutated HER2 negative breast cancer who have previously received anticancer chemotherapy under actual post-marketing use.

Clinical Study Identifier: NCT03590938

Find a site near you

Start Over

Research Site

Chiba, Japan
7.74miles
  Connect »